Limmatech Biologics Ag

This early-stage study tested a new vaccine called LTB-SA7 in 129 healthy adults to see if it is safe and triggers an immune response against Staphylococcus aureus (Staph) bacteria. Participants received either the vaccine or a placebo, and researchers monitored side effects and …

This study tested a new vaccine called Shigella4V2 to protect infants against shigellosis, a severe diarrheal disease. Researchers gave the vaccine to 110 healthy 9-month-old babies to check its safety and how well it triggers the immune system. The goal was to find the best dose…